| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Haemophilus influenzae (ciprofloxacin-susceptible) |
0.5 |
>4 |
0.25 － >4 |
Penicillin (Benzylpenicillin, Penicillin G, Bicillin C-R/L-A, Pfizerpen, Wycellin)  |
1467 |
| Haemophilus influenzae (ciprofloxacin-susceptible) |
2 |
2 |
0.12 － 2 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
1467 |
| Haemophilus influenzae (ciprofloxacin-susceptible) |
2 |
8 |
1 － 16 |
Tobramycin (Tobrex, Nebcin) |
1467 |
| Haemophilus influenzae (ciprofloxacin-susceptible) |
- |
- |
≤1 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
452 |
| Haemophilus influenzae (DILL) |
- |
- |
2 － ? |
Telithromycin (HMR 3647, RU-66647, Ketek) |
319 |
| Haemophilus influenzae (DILL) |
- |
- |
8 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
319 |
| Haemophilus influenzae (DILL) |
- |
- |
4000 － ? |
Erythromycin Analogues |
1259 |
| Haemophilus influenzae (ESBL + ampicillin-resistant) |
≤0.004 |
≤0.004 |
≤0.004 － 0.25 |
Gatifloxacin (Tequin) |
268 |
| Haemophilus influenzae (ESBL + ampicillin-resistant) |
0.004 |
0.008 |
≤0.004 － 0.5 |
Garenoxacin (T-3811, BMS-284756) |
268 |
| Haemophilus influenzae (ESBL + ampicillin-resistant) |
0.008 |
0.008 |
≤0.004 － 0.06 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
268 |
| Haemophilus influenzae (ESBL + ampicillin-resistant) |
0.008 |
0.015 |
≤0.004 － 0.25 |
DC-159a |
268 |
| Haemophilus influenzae (ESBL + ampicillin-resistant) |
0.015 |
0.015 |
≤0.004 － 0.25 |
Moxifloxacin (BAY 12-8039, Avelox) |
268 |
| Haemophilus influenzae (ESBL + ampicillin-resistant) |
1 |
2 |
0.12 － 2 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
18 |
| Haemophilus influenzae (ESBL + ampicillin-resistant) |
1 |
2 |
0.12 － 4 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
18 |
| Haemophilus influenzae (ESBL + ampicillin-resistant) |
4 |
8 |
0.25 － >32 |
Clarithromycin (Biaxin) |
18 |
| Haemophilus influenzae (ESBL + ampicillin-resistant) |
8 |
16 |
0.25 － 32 |
Clarithromycin (Biaxin) |
18 |
| Haemophilus influenzae (ESBL + ampicillin-resistant) |
- |
0.015 |
≤0.004 － 0.12 |
Levofloxacin (Levaquin, Quixin) |
268 |
| Haemophilus influenzae (ESBL + ampicillin-resistant) |
- |
- |
0.008 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
268 |
| Haemophilus influenzae (ESBL + ampicillin-resistant) |
- |
- |
0.008 － ? |
DC-159a |
268 |
| Haemophilus influenzae (ESBL + ampicillin-resistant) |
- |
- |
0.015 － ? |
Levofloxacin (Levaquin, Quixin) |
268 |
| Haemophilus influenzae (ESBL + ampicillin-resistant) |
- |
- |
0.015 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
268 |
| Haemophilus influenzae (ESBL + ampicillin-susceptible) |
1 |
2 |
0.12 － 4 |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
18 |
| Haemophilus influenzae (ESBL + ampicillin-susceptible) |
4 |
16 |
0.25 － 32 |
Clarithromycin (Biaxin) |
18 |
| Haemophilus influenzae (ESBL) |
≤0.004 |
≤0.004 |
≤0.004 － <=0.004 |
Sitafloxacin |
443 |
| Haemophilus influenzae (ESBL) |
≤0.004 |
≤0.004 |
≤0.004 － <=0.004 |
Sitafloxacin |
130 |
| Haemophilus influenzae (ESBL) |
0.004 |
0.008 |
≤0.004 － 0.008 |
DK-507k |
443 |
| Haemophilus influenzae (ESBL) |
0.004 |
0.008 |
≤0.004 － 0.015 |
DK-507k |
130 |
| Haemophilus influenzae (ESBL) |
0.004 |
0.008 |
≤0.004 － 0.03 |
Garenoxacin (T-3811, BMS-284756) |
130 |